Login to Your Account



Financings Roundup

Start-Up Ascletis Taps Chinese Investors for $100M Series A

By Jennifer Boggs


Thursday, April 7, 2011
Formed earlier this year to marry U.S. innovation and Chinese capital, start-up Ascletis Inc. pulled in a whopping $100 million in committed Series A funding, with the first $50 million tranche expected to support its dual operation strategy for about five years.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription